VINCERX PHARMA, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.8025 USD | -5.59% |
|
-8.51% | -31.99% |
| Apr. 26 | Tech Rally Boosts Exchange-Traded Funds, Equity Futures Pre-Bell Friday | MT |
| Apr. 26 | Vincerx Pharma Prices Public Offering of Shares, Warrants | MT |
Chart calendar Vincerx Pharma, Inc.
d20b3b8d2ea0b.7L5DYiOPs54M-g767yfE0N8XF2srmC-FXDBljyE3AR0.3MkNOBb3_O1Ot0XPvh6SoI51UAFPyUHcMQMEwHNAdFXa-jALROzCqU-8Sw~3e27cd72bf5603becd55c64ddee993ee
Upcoming events on Vincerx Pharma, Inc.
Past events on Vincerx Pharma, Inc.
| 2024-05-08 | Q1 2024 Earnings Release (Projected) |
| 2024-04-08 05:00 pm | Investor Meeting - Key Opinion Leader |
| 2024-04-08 04:30 pm | American Association for Cancer Research Meeting - Abstract No:3197 |
| 2024-04-08 12:00 pm | American Association for Cancer Research Meeting - Abstract No: 2051 |
| 2024-04-07 | American Association for Cancer Research Meeting |
| 2024-04-07 04:30 pm | American Association for Cancer Research Meeting - Abstract No: 629 |
| 2024-03-29 03:20 pm | Q4 2023 Earnings Release |
| 2023-12-11 09:00 pm | American Society of Hematology Meeting - Abstract #4293 |
| 2023-12-10 09:00 pm | American Society of Hematology Meeting - Abstract #2809 |
| 2023-12-09 08:30 pm | American Society of Hematology Meeting - Abstract #1435 |
| 2023-11-14 07:00 am | Q3 2023 Earnings Release |
| 2023-09-27 09:10 am | Cantor Global Healthcare Conference |
| 2023-09-11 | H.C. Wainwright Global Investment Conference |
| 2023-08-07 09:25 am | Q2 2023 Earnings Release |
| 2023-05-25 01:00 pm | Annual General Meeting |
| 2023-05-11 04:05 pm | Q1 2023 Earnings Release |
| 2023-04-19 12:00 am | American Association for Cancer Research Meeting - Abstract No 6294 |
| 2023-04-17 01:30 pm | American Association for Cancer Research Meeting - Abstract No 2722 |
| 2023-04-17 09:30 am | American Association for Cancer Research Meeting - Abstract No 1558 |
| 2023-04-16 01:30 pm | American Association for Cancer Research Meeting - Abstract No 484 |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -0,04 | -10,7 -1,30 -724.15% | -62,7 -64,1 2.26% | -71,1 -70,6 -0.7% | -42,6 -46,1 7.54% | -26,3 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | -65,4 -64,4 -1.54% | -40,2 -44,4 9.46% | -24,6 |
|
Net income Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | -65,4 -64,6 -1.21% | -40,2 -44,3 9.42% | -24,6 |
|
EPS USD | Released Forecast Spread | -0,01 | 0,00 0,00 - | 0,00 0,00 - | -3,11 -3,07 -1.3% | -1,89 -2,04 7.35% | -1,03 |
| Announcement Date | 08/10/20 | 22/03/21 | 29/03/22 | 28/03/23 | 29/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -17,7 -19,6 9.58% | -21,6 -17,8 -21.71% | -19,6 -16,9 -15.83% | -15,6 -12,9 -21.2% | -15,4 -13,0 -18.29% | -15,1 -13,1 -15.44% | -11,7 -12,7 8.43% | -10,3 -9,57 -7.78% | -5,53 -9,05 38.84% | -5,39 | -6,30 | -7,28 | -8,38 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -16,9 -12,0 -40.66% | -13,6 -12,9 -5.65% | -14,3 -9,43 -52.09% | -11,2 -12,0 7.14% | -9,72 -9,25 -5.06% | -4,95 -8,72 43.25% | -5,05 | -6,08 | -7,06 | -8,14 | |||
|
Net income Million USD | Released Forecast Spread | -16,9 -14,5 -16.41% | -13,6 -13,0 -4.61% | -14,3 -11,2 -28.59% | -11,2 -12,6 11.54% | -9,72 -9,63 -0.87% | -4,95 -8,85 44.06% | -5,05 | -6,08 | -7,06 | -8,14 | |||
|
EPS USD | Released Forecast Spread | -0,80 -0,68 -18.52% | -0,65 -0,61 -7.14% | -0,68 -0,52 -30.77% | -0,52 -0,60 12.85% | -0,46 -0,46 -0.73% | -0,23 -0,37 37.27% | -0,24 | -0,23 | -0,26 | -0,30 | |||
| Announcement Date | 29/03/22 | 12/05/22 | 11/08/22 | 10/11/22 | 28/03/23 | 11/05/23 | 07/08/23 | 14/11/23 | 29/03/24 | - | - | - | - |
| 2024-05-13 | IMMATICS N.V.: Q1 2024 Earnings Release (Projected) |
| 2024-05-13 | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-13 | PEPTIDREAM INC.: Q1 2024 Earnings Release |
| 2024-05-13 | NYKODE THERAPEUTICS: Q1 2024 Earnings Release |
| 2024-05-13 | ABL BIO INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-13 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-14 07:00 am | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 2024-05-14 | CELCUITY INC.: Q1 2024 Earnings Release |
| 2024-05-15 | BIOCON LIMITED: Q4 2024 Earnings Release |
| 2024-05-16 09:00 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
Past sector events for Vincerx Pharma, Inc.
| Today | PHARMAESSENTIA CORPORATION: Q1 2024 Earnings Release |
| Today | ALLOGENE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| Today | CEREVEL THERAPEUTICS HOLDINGS, INC.: Q1 2024 Earnings Release (Projected) |
| Today | LEGEND BIOTECH CORPORATION: Q1 2024 Earnings Release |
| Today | PEPTRON, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-10 04:02 pm | CASSAVA SCIENCES, INC.: Q1 2024 Earnings Release |
| 2024-05-10 08:26 am | ITEOS THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-10 08:00 am | PRIME MEDICINE, INC.: Q1 2024 Earnings Release |
| 2024-05-10 07:00 am | AKERO THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-09 08:05 pm | SOLENO THERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- VINC Stock
- Calendar Vincerx Pharma, Inc.